...ComGenex Inc. (Budapest, Hungary) changed its name to AMRI Hungary. In February, AMRI acquired ComGenex for...

...AMRI completed its previously announced acquisition of ComGenex for $11 million in cash (see BioCentury, Feb...
...$11 million in cash (see BioCentury, Feb. 6). Albany Molecular Research Inc. (AMRI), Albany, N.Y. ComGenex Inc....

...AMRI will acquire ComGenex for $11 million in cash. ComGenex, a chemistry services company, had $8.5...
...The deal is expected to close this quarter. Albany Molecular Research Inc. (AMRI), Albany, N.Y. ComGenex Inc....

...under which ComGenex is providing BAYG's Bayer Healthcare unit with chemistry services and compound libraries. ComGenex Inc....

...PI3 kinase inhibitors for cancer discovered through a joint discovery program with ComGenex. In 2002, ComGenex...
...2002). Last November, the partners amended the deal to give Echelon an option to acquire ComGenex's...
...in stock (see BioCentury, Jan. 10, 2004). Aeterna Zentaris Inc. (TSE:AEZ; AEZS), Quebec City, Quebec ComGenex Inc....

...and market certain PI3 kinase inhibitor cancer candidates discovered through a joint discovery program with ComGenex...
...Last November, the partners amended the deal to give Echelon an option to acquire ComGenex's...

...and inflammatory diseases (see BioCentury, Feb. 4, 2002). Echelon now has the right to acquire ComGenex's...
...from ComGenex's compound libraries that have shown efficacy in xenograft animal models against ovarian cancer. ComGenex Inc....

...optimal conditions to fold the complex proteins for full functionality. AZN will own resulting proteins. ComGenex Inc....

...sixth year their combinatorial supply deal under which ComGenex is providing compound libraries to BAYG. ComGenex Inc....